CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for NOVARTIS · Bio-pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 21, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

MINI Act HR 1672, Pharmaceutical Policy Issues

Medicare/Medicaid

MINI Act HR 1672, Pharmaceutical Policy Issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.